Objective. Patients with oral cavity squamous cell carcinoma (OCSCC) undergo adjuvant radiation for pathologically high-risk features including positive nodal disease and extracapsular spread (ECS). In the absence of these high-risk features, our objective was to determine if perineural invasion (PNI) is an independent risk factor and if adjuvant radiation (XRT) improves disease control rates.
Introduction
Perineural invasion (PNI) has been classified as an intermediate risk factor for recurrence and decreased survival. 1, 2 When identified in the setting of nodal metastasis and extracapsular spread, the addition of adjuvant therapies is a wellestablished method of treatment. Treatment decisions become more difficult in the pathologically negative neck with clear evidence of PNI when high-risk factors such as extracapsular spread (ECS) and nodal metastasis are no longer a major factor in adding adjuvant therapy. Adjuvant therapies are not without risks, and selecting the appropriate treatment regimen based on risk assessment while maintaining optimal survival outcomes is vital to the overall management of patients with oral cavity squamous cell carcinoma (OCSCC). 2 There are strong data supporting PNI as a risk factor for occult metastasis along with depth of invasion, size of primary tumor, differentiation, and immunosuppression. [3] [4] [5] The goal of identifying high-risk groups in OCSCC and treating them appropriately has been shown in numerous trials to improve survival, although the effect of PNI biologically independent of other histologic risk factors has not been studied. 1 We sought to evaluate the effect of PNI in OCSCC in patients who underwent a neck dissection and were found to have no pathologic evidence of regional metastasis (pN0), thus removing the confounding effect of N1 disease and ECS on outcomes. We hypothesized that in patients with pN0 necks, those with PNI (pN0/PNI1) would have a poorer prognosis compared to patients without PNI (pN0/PNI-). As a secondary outcome we assessed the role of adjuvant radiation (XRT) in pN0 patients based on PNI status.
Materials and Methods

Study Population and Eligibility Criteria
A historical cohort analysis of all patients treated primarily with surgery for OCSCC from 1998 to 2009 at a tertiary care center was performed. Two hundred and ninety-nine patients with OCSCC were screened for the following inclusion criteria: previously untreated patients who underwent primary surgical extirpation with a selective neck dissection and no pathologic evidence of regional metastasis or positive margins. Eighty-eight patients were identified with no evidence of regional metastasis based on pathological analysis of their neck dissection specimen. Seventy-seven percent (68/88) of patients' primary tumors had no evidence of perineural invasion (pN0/PNI-) while 23% (20/88) of patients' primary tumors were found to have pathological evidence of perineural invasion (pN0/PNI1). Demographics of the pN0/PNI1 and pN0/PNI-cohorts are shown in Table 1 . There were no differences between the pN0/PNI1 and pN0/PNI-groups by age, gender, smoking or alcohol status, T-classification, margin control, tumor grade, perivascular invasion, tumor subsite, or median follow-up.
Treatment Plan
All patients were evaluated clinically and underwent direct laryngoscopy and esophagoscopy to confirm resectability and evaluate for second primaries. Primary extirpation with 1 cm margins was at the discretion of the attending surgeon. All patients in the study underwent neck dissection based on depth of invasion .2 mm and clinical or radiographic evidence of regional metastasis and/or advanced stage (AJCC stage III or IV). The extent of neck dissection was at the discretion of the operating surgeon based on tumor location. The minimum neck dissection was a selective level I-III unilateral neck dissection with the exception of 1 pN0/PNIpatient who underwent a selective level I-II neck dissection. Adjuvant radiation treatment was recommended for patients with positive margins and advanced T-classification; however, there were 12 patients in this cohort with T3/T4 tumors who did not receive adjuvant radiation based on physician preference, patient refusal, and young age. In the pN0/ PNI1 group, 6 patients did not receive adjuvant radiation based on young age, determination of the multidisciplinary tumor board, or patient refusal. Patients with PNI (pN0/PNI1) were significantly more likely to undergo postoperative radiation therapy compared to patients without PNI (pN0/ PNI-) (70% [14/20] vs 31% [21/68]; P = .0034). In the pN0/ PNI1 group, 1 of 20 (5%) refused radiation and received Xeloda alone.
Pathologic Analysis of Perineural Invasion
All patients identified in the database with PNI were analyzed by a head and neck pathologist (JBM) for extent of perineural invasion, size of nerve invasion, and intraneural invasion. Extent of PNI was categorized as focal (1 focus of PNI), moderate (2-5 foci of PNI), or extensive (.5 foci of PNI). Size of nerve invasion was categorized as small (nerve size \1 mm) or large (nerve size 1 mm). Intraneural invasion was defined as cancer invasion through the nerve epineurium. Three patient blocks were unavailable for further analysis.
Statistical Analysis
The outcomes of interest were overall survival (OS), disease-specific survival (DSS), local-regional control (LRC), and disease-free interval (DFI). Overall survival was defined as time from diagnosis of first primary to death by any cause; DSS was defined as the time from diagnosis of first primary to death from OCSCC, where the occurrence of a second primary was treated as a censored event. Localregional control was defined as time from treatment to local and/or regional recurrence. Disease-free interval was defined as time from treatment to any type of recurrence. Patients who were alive and free of disease at last follow-up were censored at the last inquiry to the Social Security Death Index for survival and date of last follow-up for LRC and DFI.
The Kaplan-Meier method and the log-rank test were used to test for differences in the survival functions between strata defined by clinical variables. For descriptive purposes, we show the survival functions for patients with perineural invasion who did and did not undergo postoperative radiation therapy. Univariable and multivariable Cox models were used to explore the associations of clinical variables with time-to-event outcomes. Multivariate analysis was performed for OS, DSS, LRC, and DFI using all potential covariates and implementing a backward selection algorithm with selection criteria set at a P-value of .15 to obtain parsimonious models. Each test may be limited by the sample size, especially in subgroup comparisons of the outcomes based on adjuvant radiation in the pN0/PNI1 group; therefore, a nonsignificant result does not eliminate the possibility that a relationship exists. All statistical analyses were done using SAS version 9.2 (SAS Institute, Carey, North Carolina). A two-tailed P-value of .05 or less was considered statistically significant.
The data for this manuscript are approved by the Institutional Review Board at the University of Michigan.
Results
The overall failure rate was 25% (22/88). There was a significant difference in the local failure rate in the pN0/PNI1 group (35%, 7/20) compared to the pN0/PNI-group (12%, 8/68), P = .037. There was not a significant difference in the regional failure rate (10%, 2/20 vs 10.2%, 7/68), P = 1.0, or the distant failure rate (5%, 1/20 vs 6%, 4/68), P = 1.0.
Univariate analysis demonstrated pN0/PNI1 patients had significantly worse LRC (P = .021), DFI (P = .031), and DSS (P = .031) than pN0/PNI-patients, while there was a trend toward a significant difference in OS (P = .096) between the 2 groups (Figure 1 A-C) . The 3-and 5-year survival estimates between pN0/PNI1 and pN0/PNI-are shown in Table 2 . Perivascular invasion conferred a worse DFI (P = .028) and LRC (P = .008) ( Table 3) . Given that all patients in this cohort were pN0 and there were only 22 disease-related outcomes, there is inadequate sample to show expected differences with univariate testing of gender, tobacco use, tumor grade, T-classification, and AJCC stage on OS, DSS, LRC, or DFI.
Multivariable Cox regression analysis controlling for age, gender, tobacco and alcohol use, positive margins, tumor grade, perivascular invasion, T-classification, AJCC stage, chemotherapy, and radiation therapy was performed. The variable pN0/PNI1 compared to pN0/PNI-showed significantly worse DFI (P = .012) and LRC (P = .005), while there was a trend toward significance in OS (P = .09) and DSS (P = .07). In this multivariate model, perivascular invasion was significantly associated with worse DFI (P = .012) ( Table 3) .
To assess the effect of adjuvant radiation therapy on pN0/ PNI1 patients, subset analysis of 14 pN0/PNI1 patients who received adjuvant radiation were compared to 6 pN0/PNI1 patients who did not receive adjuvant radiation. Local regional control rates were significantly improved in pN0/ PNI1 patients treated with adjuvant radiation compared to those who did not receive adjuvant radiation (6.7 years vs 1.9 years, respectively; P = .047) (Figure 2A) . The mean disease-free interval was significantly improved in pN0/ PNI1 patients treated with radiation versus those who did not undergo radiation treatment (6.5 years vs 1.7 years, respectively; P = .012). While adjuvant radiation for pN0/ PNI1 patients resulted in improved LRC and DFI, it did not result in significant improvement for DSS (P = .8) or OS (P = .68) ( Figure 2B and C) .
To assess for potential bias between the pN0/PNI1 group who underwent and did not undergo adjuvant radiation, comparison of differences in T-classification and tumor grade was performed. In the pN0/PNI1 group who underwent adjuvant radiation, a greater proportion had advanced stage tumors (T3/4) compared to patients who did not undergo adjuvant radiation (71% vs 50%, respectively). In this cohort, there was 1 patient with poorly differentiated squamous cell carcinoma. In the pN0/PNI1 group who received adjuvant radiation, 82.3% had well-moderate differentiated tumors compared to 100% in pN0/PNI1 group who did not undergo adjuvant radiation. Despite more advanced T-classification in the pN0/PNI1 group receiving adjuvant radiation, LRC (P = .047) and DFI (P = .012) are significantly improved compared to the pN0/PNI1 group who did not undergo adjuvant radiation therapy ( Table 2) .
To further assess treatment failures in the pN0/PNI1 group who received adjuvant radiation versus those who did not, descriptive analysis of all patients with local, regional, or distant failures in the pN0/PNI1 group was performed. Comparison of pN0/PNI1 patients who received adjuvant radiation versus those who did not demonstrated 21% (3/14) versus 67% (4/6) failed locally, 0% (0/14) versus 17% (1/6) failed regionally, and 7% (1/14) versus 17% (1/6) had distant failures, respectively.
The histologic descriptors of perineural invasion (extent of PNI [focal, moderate, and extensive], type of nerve involved [small vs large], and intraneural vs extraneural invasion) were also analyzed. Fifty-three percent of pN0/ PNI1 patients had extensive PNI (9/17) compared to 35% (6/17) having focal PNI and only 6% (1/17) with moderate PNI. Small nerves were predominantly involved (92%) compared to large nerves (8%) and the vast majority (79%) had extraneural invasion. There was no correlation of these histologic descriptors of PNI to type of failure; however, this subset analysis was underpowered.
Discussion
While PNI is often regarded as an intermediate risk factor, this study demonstrates that in the absence of pathologic evidence of nodal metastasis, PNI portends a worse DSS, LRC, and DFI in patients treated surgically for OCSCC. PNI in the absence of nodal disease or positive margins increases the risk of local regional failure by 5 times and shortened disease-free interval by 3 times. Adjuvant radiation therapy appears to improve LRC and DFI in patients with PNI.
Several studies have sought to analyze the effect of PNI in OCSCC patients with N0 neck disease. Liao et al analyzed 460 patients with clinical T1-3 and N0 neck disease; however, 15% of their patients did not undergo neck dissections. 6 Similar to our study, they found a significantly increased regional recurrence rate in the PNI1 group but found no benefit for their PNI1 patients undergoing adjuvant radiation treatment.
By using pathologically N0 patients, we are better equipped to analyze the true effect of PNI independent of known high-risk features. We sought to evaluate OCSCC patients with no evidence of regional metastasis based on pathologic analysis after neck dissection to more accurately define a group of patients who were biologically independent of the known risk factors (ECS, N1 and positive margins) for poor outcomes.
The next logical question after identifying PNI as an independent risk factor for poor outcome is to examine treatment options to modify the negative effects of PNI. In this study, adjuvant radiation appears to improve LRC and DFI despite more advanced stage tumors in the group receiving adjuvant radiation. The 2012 National Comprehensive Cancer Network (NCCN) recommends at least adjuvant radiation for T1-4N0 OCSCC with adverse features. 7 While adjuvant radiation has risks, the risk must be weighed against outcomes. [8] [9] [10] [11] In the study cohort local treatment failures were significantly higher in the pN0/PNI1 group compared to the pN0/PNI-group while there was no difference comparing regional or distant failures. In patients who are pN0/PNI1, our findings support the NCCN guidelines for adjuvant radiation in pN0/PNI1 patients. In our analysis 83% of pN0/ PNI1 patients who did not receive adjuvant radiation treatment experience local-regional failure whereas 21% who did receive adjuvant radiation treatment had local-regional failures. These findings are limited by sample size, but the addition of adjuvant radiation seems to improve local regional control and disease-free interval. Although we acknowledge the small sample size, this is one of the largest reviews of PNI as an isolated risk factor. Given the controversy in the literature regarding PNI as an absolute indication for adjuvant radiation, a larger randomized prospective trial would better answer the question of the role of adjuvant radiation for the pN0/PNI1 patient. 6, 8, 9 Overall, PNI was shown to be an independent risk factor for reduced DSS, LRC, and DFI. Previous work has shown histologic subtypes of PNI correlate with OS and LRC. 12, 13 However in the present study histologic subtypes of PNI did not correlate with risk of recurrence or poor outcomes. The number of patients in our subset analysis is small and would require a larger analysis to determine if the pattern of PNI is predictive of outcome. Interestingly, perivascular invasion was significantly associated with worse DFI and LRC. However, there were only 5 patients in the entire cohort with PVI. Given the small sample size, the effect of PVI is underpowered to make any valid conclusions.
Future studies evaluating a larger cohort of patients with different histologic subtypes of PNI may allow for a risk stratification for prognosis and treatment. In addition, better understanding the molecular mechanisms of PNI is imperative to identifying high-risk groups and potentially mediating the mechanism of perineural spread in HNSCC.
Conclusion
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